Med Tech Market Reports


Online business intelligence
for the medical technology
and biopharma industry,
supplied through Piribo

Biotechnology

Title Publication Date Price
DNA Sequencing
Technologies, Markets and Companies
January 2010 £1115
Cell Therapy
Technologies, Markets and Companies
January 2010 £3090
Chinese Markets for Monoclonal Antibody January 2010 £2470
Targeting Cancer Stem Cells
Emerging Therapeutic, Therapeutic Strategies and Pipeline Developments (2010)
January 2010 £1599
Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
Equipment, Tools, Technologies, Opportunities & WW Market Outlook
January 2010 £1015
Nanobiotechnology
Applications, Markets and Companies
January 2010 £2780
Cytogenetics
Technologies, Markets and Companies
January 2010 £1360
Antiviral Therapeutics
Technologies, Markets and Companies
January 2010 £1980
Biomarkers
Technologies, Markets and Companies
January 2010 £2780
Gene Therapy
Technologies, Markets and Companies
January 2010 £2780
Drug Delivery to Central Nervous System Diseases
Technologies, Markets and Companies
January 2010 £1730
Proteomics
Technologies, Markets and Companies
January 2010 £2780
RNAi
Technologies, Markets and Companies
January 2010 £2165
Transdermal Drug Delivery
Technologies, Markets and Companies
January 2010 £1730
Pain Therapeutics
Drugs, Markets and Companies
January 2010 £2165
Proteomics
Technologies, Markets and Companies
January 2010 £2780
Regenerative Medicine
Global Market Trends
November 2009 £1850
Biotechnology Instrumentation
International Market Trends
November 2009 £1850
The Future of Biosimilars
Market Forecasts to 2015
December 2009 £2165

Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with double-figure growth noticeably higher that that of the overall pharmaceutical market. This report will help you to understand those developments and their significance. That report provides valuable commercial information on this exciting industry that no healthcare company should ignore. read more ...

Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools, technologies, products and services. This report suggests the future direction of the market for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or tests used in the next-generation of drug R&D. This study sizes the world market and growth rate of biomarkers and assays for drug R&D spending to 2012. Read more ...

RNA interference markets
Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry analysts predict that RNA interference (RNAi) may even surpass PCR as a top technology. Read more ...

Report: Molecular Diagnostics. Technologies, Markets and Companies
This best-selling report
describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. Aimed at chief executives and chief development officers, it is the most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. It includes profiles of 250 companies more ...

Drug Delivery in Cancer Technologies, Markets and Companies
May 2009 £1990
Nitric Oxide: Therapeutics, Markets and Companies
May 2009 £1855
RNAi Technologies, Markets and Companies
May 2009 £1990
Cell Therapy Technologies, Markets and Companies
May 2009 £2985
Cell Culture: The World Market for Media, Sera and Reagents. 2nd Edition
May 2009 £2650
DNA Sequencing. Technologies,Markets and Companies
May 2009 £665
A Quick Guide to Biotechnology and Healthcare in the Middle East
April 2009 £190
6th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
April 2009 £1120
Companion Biomarkers in Drug Development
April 2009 £2255
Biotechnology in the US. IBISWorld Industry Report
March 2009 £430
Bioinformatics Markets. Strategies, Business Models and Trends for the Future
March 2009 £2255
The Future of Biobanks. Regulation, ethics, investment and the humanization of drug discovery
March 2009 £2025
The Future of Biobanks. Regulation, ethics, investment and the humanization of drug discovery
March 2009 £2025

More reports
Click on a title to see a summary of the report on Piribo

 

To top